Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
C.DhingraN.KumarR.et al (2008)
Poster Session I - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.02 - SECONDARY PREVENTION P401 - ESOC25-2440 CEREBROSPINAL FLUID ANALYSIS OF AMYLOID A1-42 AND P-TAU IN TRANSIENT ISCHEMIC ATTACK PATIENTS AND HEALTHY CONTROLS Bhavana Gill 1,2 , Ryan Muir 2,3,4 , Britney Denroche 2,4 , Henrik Zetterberg 5 , Amith Sitaram 4,6 , Philip Barber 2,4 1 University of Calgary, Hotchkiss Brain Institute, Calgary, Canada, 2 Alberta Health Services, Calgary, Canada, 3 University of Toronto, Toronto, Canada, 4 University of Calgary, Calgary, Canada, 5 University of Gothenburg, Gteborg, Sweden, 6 University of Glasgow, Glasgow, United Kingdom Background and Aims: Individuals who experience transient ischemic attacks (TIAs) are 5 times more likely to develop dementia
These findings were correlated with levels of Von Willebrand Factor (VWF) or ADAMTS13 activity, involved in arterial thrombotic pathologies (97)
the Glow Blend, a multi-peptide formulation combining BPC-157, TB-500, and GHK-Cu for researchers designing multi-pathway regenerative protocols
